Halozyme Therapeutics, Inc.
HALONASDAQNASDAQ Global Select·USD·Closed
$71.71
−$1.63 (2.22%)
$71.71
−$1.63 (2.22%)
Not investment advice.Learn more
HALO has more going for it than against it right now.
We couldn't find any financial data for HALO. Please try again later.
Continue with finqOS
SEC filings, earnings transcripts, insider trades, institutional ownership, 175+ screening metrics, and an infinite research canvas.
14-day free trial · No credit card required
52W Range
Mid-range
Volume
Market Cap
Mid-cap company
P/E Ratio
Moderately valued
Div Yield
No dividend